Related Experiment Video
Updated: Mar 2, 2026

07:31
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.5K
A Pharmacotherapy Capstone Course to Target Student Learning and Programmatic Curricular Assessment
Joseph J Saseen, Sunny A Linnebur, Laura M Borgelt
1University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Anschutz Medical Campus, Aurora, Colorado.
American Journal of Pharmaceutical Education
|May 13, 2017
Summary
The University of Colorado
Area of Science:
- Pharmacy Education
- Pharmacotherapy Training
Background:
- The University of Colorado implemented a pharmacotherapy capstone course from 2002-2014.
- This 9-credit hour course served as the final academic preparation before Advanced Pharmacy Practice Experiences (APPEs).
Purpose of the Study:
- To evaluate the effectiveness of a pharmacotherapy capstone course for student learning.
- To assess the course's role in programmatic curricular evaluation and improvement.
Main Methods:
- Utilized complex patient cases and active learning methodologies to assess student knowledge and skills.
- Analyzed student performance data from written and verbal evaluations (2012-2014), surveys, and self-assessments.
Main Results:
- Student performance indicated successful learning within the course.
- Students reported increased confidence in critical thinking, problem-solving, decision-making, and lifelong learning during APPEs.
- Course outcomes informed curriculum revisions, including prerequisite courses and the development of a new clinical capstone.
Conclusions:
- The pharmacotherapy capstone course effectively prepared students for Advanced Pharmacy Practice Experiences.
- The course provided valuable data for curriculum enhancement and the development of a renewed educational program.
Related Concept Videos
Drug Administration and Therapy Phases: Overview
1.6K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.6K
Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Drug Therapy
331
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
331
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
55
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
55
Desensitization and Tachyphylaxis
3.3K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.3K
Dosage Regimens: Designs and Approaches
402
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
402

